Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Til R Kiderlen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncology Research and Treatment|March 6, 2017
HIV-Associated Lung CancerTil R Kiderlen, Jan Siehl, Marcus Hentrich
Case Reports in Dermatology|September 26, 2022
Immunochemotherapy - A Missed Opportunity for Metastasized Malignant Melanoma? Reporting a Therapeutic Success with Checkpoint Inhibitor Rechallenge after Cytotoxic Immuno-Priming in a Heavily Pretreated PatientTil R Kiderlen, Nicola Delmastro, Friedemann Jobst, et al.
Plos One|September 28, 2013
Cross-sectional study assessing HIV related knowledge, attitudes and behavior in Namibian public sector employees in capital and regional settingsTil R Kiderlen, Michael Conteh, Stephanie Roll, et al.
Journal of Infection and Public Health|March 26, 2015
Cross-sectional study assessing HIV-related knowledge, attitudes and behavior in the Namibian truck transport sector: Readjusting HIV prevention programs in the workplaceTil R Kiderlen, Michael Conteh, Stephanie Roll, et al.
International Journal of Hematology|July 26, 2021
Retrospective comparison of reinfusion procedures and subsequent leukopenia in autologous stem cell transplantationTil R Kiderlen, Lisa Ronneburger, Lore Marretta, et al.
European Journal of Cancer Care|October 12, 2022
Controlled non-randomised before-after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients-The Easy Vaccination in Oncology (EVO) strategyTil R Kiderlen, Katrin Trostdorf, Nicola Delmastro, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release AssaysF A Ottilie Neumann, Markus Müller, Gregor Mattert, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncology Research and Treatment|March 6, 2017
HIV-Associated Lung CancerTil R Kiderlen, Jan Siehl, Marcus Hentrich
Case Reports in Dermatology|September 26, 2022
Immunochemotherapy - A Missed Opportunity for Metastasized Malignant Melanoma? Reporting a Therapeutic Success with Checkpoint Inhibitor Rechallenge after Cytotoxic Immuno-Priming in a Heavily Pretreated PatientTil R Kiderlen, Nicola Delmastro, Friedemann Jobst, et al.
Plos One|September 28, 2013
Cross-sectional study assessing HIV related knowledge, attitudes and behavior in Namibian public sector employees in capital and regional settingsTil R Kiderlen, Michael Conteh, Stephanie Roll, et al.
Journal of Infection and Public Health|March 26, 2015
Cross-sectional study assessing HIV-related knowledge, attitudes and behavior in the Namibian truck transport sector: Readjusting HIV prevention programs in the workplaceTil R Kiderlen, Michael Conteh, Stephanie Roll, et al.
International Journal of Hematology|July 26, 2021
Retrospective comparison of reinfusion procedures and subsequent leukopenia in autologous stem cell transplantationTil R Kiderlen, Lisa Ronneburger, Lore Marretta, et al.
European Journal of Cancer Care|October 12, 2022
Controlled non-randomised before-after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients-The Easy Vaccination in Oncology (EVO) strategyTil R Kiderlen, Katrin Trostdorf, Nicola Delmastro, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release AssaysF A Ottilie Neumann, Markus Müller, Gregor Mattert, et al.
Pageof 1